Technical Analysis for ABEO - Abeona Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 2.86 0.00% 0.00
ABEO closed unchanged on Friday, August 7, 2020, on 65 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ABEO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Outside Day Range Expansion 0.00%
20 DMA Resistance Bearish -3.05%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.05%
Bollinger Band Squeeze Range Contraction -3.05%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Biotechnology Biology Emerging Technologies Molecular Biology Gene Therapy Genetics Genetic Engineering Genome Editing Adeno Associated Virus Cas9 CRISPR AAV Severe And Rare Diseases Fanconi Anemia

Is ABEO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.19
52 Week Low 1.35
Average Volume 880,133
200-Day Moving Average 2.82
50-Day Moving Average 2.98
20-Day Moving Average 2.92
10-Day Moving Average 2.90
Average True Range 0.17
ADX 14.03
+DI 19.96
-DI 19.49
Chandelier Exit (Long, 3 ATRs ) 3.00
Chandelier Exit (Short, 3 ATRs ) 3.22
Upper Bollinger Band 3.08
Lower Bollinger Band 2.76
Percent B (%b) 0.31
BandWidth 11.16
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.0064
Fundamentals Value
Market Cap 115.22 Million
Num Shares 40.3 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -4.69
Price-to-Sales 831.55
Price-to-Book 7.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.06
Resistance 3 (R3) 3.06 2.99 3.02
Resistance 2 (R2) 2.99 2.94 2.99 3.01
Resistance 1 (R1) 2.93 2.91 2.96 2.93 3.00
Pivot Point 2.86 2.86 2.88 2.86 2.86
Support 1 (S1) 2.80 2.81 2.83 2.80 2.72
Support 2 (S2) 2.73 2.78 2.73 2.71
Support 3 (S3) 2.67 2.73 2.70
Support 4 (S4) 2.67